AU2005200832B2 - Method and apparatus for automatic analysis - Google Patents
Method and apparatus for automatic analysis Download PDFInfo
- Publication number
- AU2005200832B2 AU2005200832B2 AU2005200832A AU2005200832A AU2005200832B2 AU 2005200832 B2 AU2005200832 B2 AU 2005200832B2 AU 2005200832 A AU2005200832 A AU 2005200832A AU 2005200832 A AU2005200832 A AU 2005200832A AU 2005200832 B2 AU2005200832 B2 AU 2005200832B2
- Authority
- AU
- Australia
- Prior art keywords
- electrode
- electrodes
- sample
- current
- potential
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims description 33
- 238000004458 analytical method Methods 0.000 title description 6
- 239000000523 sample Substances 0.000 claims description 49
- 239000003153 chemical reaction reagent Substances 0.000 claims description 25
- 239000007788 liquid Substances 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 6
- 238000000151 deposition Methods 0.000 claims description 4
- 239000007795 chemical reaction product Substances 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims 1
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 15
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 10
- 238000005259 measurement Methods 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 8
- 239000012491 analyte Substances 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 238000009792 diffusion process Methods 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000010408 film Substances 0.000 description 5
- 229910052763 palladium Inorganic materials 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 229910052697 platinum Inorganic materials 0.000 description 4
- VDJKJPMLWJWQIH-UHFFFAOYSA-M 5-ethylphenazin-5-ium;ethyl sulfate Chemical compound CCOS([O-])(=O)=O.C1=CC=C2[N+](CC)=C(C=CC=C3)C3=NC2=C1 VDJKJPMLWJWQIH-UHFFFAOYSA-M 0.000 description 3
- 108090000854 Oxidoreductases Proteins 0.000 description 3
- 102000004316 Oxidoreductases Human genes 0.000 description 3
- 229920002301 cellulose acetate Polymers 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- -1 hydrogen sulphide Chemical class 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 2
- KVZLHPXEUGJPAH-UHFFFAOYSA-N 2-oxidanylpropanoic acid Chemical compound CC(O)C(O)=O.CC(O)C(O)=O KVZLHPXEUGJPAH-UHFFFAOYSA-N 0.000 description 2
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 229920002799 BoPET Polymers 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 2
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 2
- 102000000019 Sterol Esterase Human genes 0.000 description 2
- 108010055297 Sterol Esterase Proteins 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 238000004544 sputter deposition Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- USAYMJGCALIGIG-UHFFFAOYSA-N 2,3-dichlorocyclohexa-2,5-diene-1,4-dione Chemical compound ClC1=C(Cl)C(=O)C=CC1=O USAYMJGCALIGIG-UHFFFAOYSA-N 0.000 description 1
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
- HWKRAUXFMLQKLS-UHFFFAOYSA-N 2-oxidanylidenepropanoic acid Chemical compound CC(=O)C(O)=O.CC(=O)C(O)=O HWKRAUXFMLQKLS-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 108010025188 Alcohol oxidase Proteins 0.000 description 1
- 108010015428 Bilirubin oxidase Proteins 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 1
- 102000057621 Glycerol kinases Human genes 0.000 description 1
- 108700016170 Glycerol kinases Proteins 0.000 description 1
- 108010073450 Lactate 2-monooxygenase Proteins 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- 102100022119 Lipoprotein lipase Human genes 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 108010042687 Pyruvate Oxidase Proteins 0.000 description 1
- 108010092464 Urate Oxidase Proteins 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 239000000182 glucono-delta-lactone Substances 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 108010054790 glycerol-3-phosphate oxidase Proteins 0.000 description 1
- 150000002443 hydroxylamines Chemical class 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Description
-1-
AUSTRALIA
PATENTS ACT 1990 COMPLETE SPECIFICATION FOR A STANDARD PATENT
ORIGINAL
Name of Applicant: Actual Inventors: LifeScan, Inc.
lan Andrew Maxwell and Thomas William Beck and Alastair Mclndoe Hodges Address for Service is: SHELSTON IP Margaret Street SYDNEY NSW 2000 CCN: 3710000352 Attorney Code: SW Telephone No: Facsimile No.
(02) 97771111 (02) 9241 4666 Invention Title: METHOD AND APPARATUS FOR AUTOMATIC ANALYSIS Details of Original Application No. 44461/02 dated 30 May 2002 The following statement is a full description of this invention, including the best method of performing it known to us:- File: 27001AUP02 500539321 1.DOC/5844 t la C~ TITLE: METHOD AND APPARATUS FOR AUTOMATIC ANALYSIS )FIELD OF THE INVENTION c This invention relates to a method for analysing the concentration of an analyte in a sample and to automatic analysing apparatus. The invention will be described herein with e¢3 00 5 particular reference to a method and apparatus for measuring the concentration of glucose C or other analytes in blood but is not limited to that use.
BACKGROUND ART In our copending applications PCT/AU/00365, PCT/AU/00723, and PCT/AU/00724 (the disclosures of which are incorporated herein by reference) we have described a method for determining the concentration of an analyte in a carrier. In that method a sample to be analysed is brought into contact with a reagent containing an enzyme and a redox mediator in an electrochemical cell. The cell is a thin layer cell comprising a working electrode spaced apart from a counter electrode by a spacer which ensures that the two electrodes have substantially identical area and predetermined spacing. The spacing between the electrodes is essentially close so that after a potential is applied between the electrodes, reaction products from the counter electrode migrate to the working electrode and vice versa, eventually establishing a steady state concentration profile between the electrodes which in turn results in a steady state current.
It has been found that by comparing a measure of the steady state current with the time rate at which the current varies in the current transient before the steady state is achieved, the diffusion coefficient of the redox mediator can be measured as well as its concentration. It can be shown that over a restricted time range a plot a ln(i/is,-l) vs time (measured in seconds) is linear and has a slope (denoted by S) which is equal to -4p 2
D/L,
where is the current at time "iss" is the steady state current, is the diffusion -2coefficient in cm 2 /sec, is the distance between the electrodes in cm and is the constant pi, approximately 3.14159. The concentration of reduced mediator present when N the potential was applied between the electrodes is given by -2p 2 i,,/FALS, where is C, Faraday's constant, A is the working electrode area and the other symbols are as given 00 5 above. As this later formula uses S it includes the measured value of the diffusion N, coefficient.
SSince L and the electrode area are constants for a given cell, measurement ofi as a function of time and enable the value of the diffusion coefficient of the redox mediator to be calculated and the concentration of the analyte to be determined. In our copending application PCT/AU/00724 there are described methods suitable for mass production of cells having a substantially constant electrode separation L and electrode area A.
Currently glucose in blood samples is measured in pathology laboratories and the like by means of apparatus such the YSI blood analyser in which successive samples are analysed by means of a hollow cylindrical probe in which is mounted a silver and a platinum electrode. The face of the probe is fitted with a three layer membrane. The middle layer contains an immobilised enzyme which is sandwiched between a cellulose acetate and a polycarbonate membrane. The face of the probe, covered by the membrane, is situated in a buffer filled sample chamber into which successive samples are injected.
Some of the sample diffuses through the membrane. When it contacts the immobilised oxidase enzyme it is rapidly oxidised producing hydrogen peroxide, the glucose forming a glucono-delta-lactone.
The hydrogen peroxide is in turn oxidised at the platinum anode producing electrons.
A dynamic equilibrium is achieved when the rate of peroxide production and removal -3reach a steady state. The electron flow is linearly proportioned to the steady state peroxide Sconcentration and therefore to the concentration of the glucose.
The platinum electrode is held at an anodic potential and is capable of oxidising N many substances other than hydrogen peroxide. To prevent these reducing agents from 00 C€3 5 contribution to sensor current, the membrane contains an inner layer consisting of a very N,1 thin film of cellulose acetate. This film readily passes hydrogen peroxide but excludes Schemical compounds with molecular weights above approximately 200. The acetate film also protects the platinum surface from proteins, detergents, and other substances that could foul it. However the cellulose acetate film can be penetrated by compounds such as hydrogen sulphide, low molecular weight mercaptans, hydroxylamines, hydrozines, phenols and analytes.
In use, the sample (or a calibration standard) is dispensed in to the chamber, diluted into 600 microlitres of buffer, and then a measurement is made by the probe. The sensor response increases and then reaches a plateau when a steady state is reached. After several seconds a buffer pump flushes the chamber and the sensor response decreases.
The apparatus monitors the base line current. If it is unstable a buffer pump will continue to flush the sample chamber with buffer. When a stable base line is established an automatic calibration is initiated. The apparatus calibrates itself for example after every five samples or 15 minutes. If a difference of more than 2% occurs between the present and previous calibration, the apparatus repeats the calibration. Recalibration also occurs if the sample chamber temperature drifts by more than 1VC.
The apparatus described suffers from a number of disadvantages. Firstly, a high proportion of its time in use is spent in performing calibrations rather than analysis.
-4- SFurthermore the consumption of buffer and calibrating solutions is a substantial cost.
Another disadvantage is that as the enzyme membrane ages, a graph of reading versus t concentration becomes non-linear. It would be highly desirable to provide apparatus which is able to make measurements of the kind described with improved speed, efficiency, and at 00 5 lower running cost.
SOBJECT OF THE INVENTION O An object of the present invention is an improved method and apparatus for automatically analysing samples which avoids or ameliorates at least some of the disadvantages of prior art. An object of the preferred embodiment of the invention is an automatic apparatus for estimating the concentration of glucose in samples of blood.
BRIEF DISCLOSURE OF THE INVENTION According to a first aspect the invention provides a method for estimating the concentration of a reduced or oxidised form of a redox species in a liquid comprising the steps of: contacting an area of a first electrode with a sample of predetermined volume of the liquid, bringing a second electrode into a closely spaced relationship with the first electrode, thereby contacting the sample with an area of the second spaced apart from the first electrode, wherein step is conducted after step and wherein at least one of the electrodes includes a reagent positioned thereon, applying a potential between the electrodes while the electrodes are sufficiently closely spaced that reaction products formed at each electrode diffuse to the other electrode while the potential is applied, reversing the potential between the electrodes,
O
O
measuring or estimating a value indicative of the change in current as a function if time and a value indicative of the steady state current, and N determining from said value, said current as a function of time, and said steady state current the concentration of reduced or oxidised form of the species in the liquid sample.
0 5 Unless the context clearly requires otherwise, throughout the description and the claims, the words 'comprise', 'comprising', and the like are to be construed in an inclusive sense as opposed to an exclusive or exhaustive sense; that is to say, in the sense of "including, but not limited to".
Any discussion of the prior art throughout the specification should in no way be considered as an admission that such prior art is widely known or forms part of common general knowledge in the field.
BRIEF DESCRIPTION OF THE DRAWINGS Various embodiments of the invention will now be described by way of example only with reference to the accompanying drawings wherein: Figure 1 is a schematic diagram showing in cross-section a first embodiment of apparatus according to the invention.
Figure 2 is a schematic diagram showing, in enlarged cross-section, a sample droplet between two electrodes.
Figure 3 is schematic diagram showing in cross-section a second embodiment of apparatus according to the invention.
Figure 4 is a schematic diagram of a third embodiment of apparatus according to the invention in side elevation.
Figure 5 shows the embodiment of figure 4 in end elevation, viewed on line 5-5 of Figure 4.
-6- C, DESCRIPTION OF PREPARED EMBODIMENTS SBy way of example a first embodiment of apparatus according to the invention will Sbe described.
With reference to Figure 1 there is shown schematically an automatic analyser for 00 measuring glucose in blood samples. The apparatus comprises a flexible first electrode 1 consisting of a palladium layer 2 formed or deposited onto a flexible carrier 3 (for example a 100 micron PET film) preferably by sputter coating to a thickness of for example 100- 1000 angstrom. Electrode 1 is fed into the analyser from a roll (not illustrated) in the form of a tape.
First electrode 1 is provided on palladium surface 2 with an enzyme and a redox mediator. These may be selected (without limitation) from the systems in table 1 and in the present example a GOD enzyme and ferricyanide mediator are used. The enzyme and redox mediator may be printed in predetermined quantities at predetermined intervals on the first electrode surface as a dried reagent coating 4.
Electrode 1 is driven by means not shown in the drawings through a sample station at which a precise volume of a sample 1 is placed as a droplet 5 on a reagent coating 4 on electrode surface 1, for example, by means of an automatic pipette 6. Less preferably, predetermined quantities of enzyme and redox mediator may be combined with the sample before or after deposition of the droplet on the electrode.
A second electrode 11 which in the present example is of similar construction to the first electrode, and comprising a palladium layer 12 sputter coated onto a flexible PET carrier 13, is then brought into closely spaced relationship with electrode 1 and into contact with a droplet 5. The droplet wets both palladium surfaces 1 and 10 and adopts a substantially cylindrical configuration between the two electrodes as more clearly C illustrated in Figure 2. The droplet is bounded intermediate electrodes 1, 2 by a liquid/gas Sinterface 14.
SAn electric potential is then applied to the two electrodes (by means not illustrated in Figure 1) via contacts.
0 5 As described in our co-pending applications PCT/AU96/00723 and C PCT/AU96/00724, the potential between the electrodes is set such that the rate of electro- Soxidation of the reduced form of the species (or of electro-reduction of the oxidised form) is diffusion controlled. Because the working and counter electrodes are placed in very close proximity (about 0.5 mm apart or less) ferricyanide that is generated at the counter electrode has time to reach the working electrode and contribute to the current at the working electrode. That is, a ferricyanide molecule can be reduced at the counter electrode to ferrocyanide, and can then diffuse to the working electrode, where it will be re-oxidised to ferricyanide. This situation results in a decreasing current at short times that steadies to reach a constant value at longer times (the steady state current). This steadying of the current occurs because a constant stream of ferrocyanide is being supplied to the working electrode from the counter electrode. This mechanism is quite distinct from that which occurs in a Cottrell device in which the electrodes are separated so that ferricyanide that results from the reduction of ferricyanide at the counter electrode does not influence the observed current.
In the present cell the steady state current is given by 2DFAC o i= F ss
L
wherein iss is the steady state current, D is the diffusion coefficient, F is the Faraday constant, A is the area of the electrode, Co is the concentration of the analyte (ferricyanide) and L is the separation of the electrodes.
-8- The current i at time t is given by the equation: S-4p 2 n 2 Dt i=is(1 +2 e L c n=l c where p is pi.
0 At longer times the higher exponential terms in equation 2 can be ignored. Therefore equation 2 can be approximated by equation 3 for times greater than a certain value 0 -4p2Dt Si iss(l+ 2 exp If it is assumed that equation 2 can be approximated by equation 3 when the second exponential term in equation 2 is 1% of the first exponential term, equation 3 is valid for 0.0389L 2 times greater than t=
D
It will be understood that Equation 3 can be transformed to give: ln )=ln(2)-4p 2 2 iss L So a plot of the left hand side of equation versus time will give a straight line with new Dt slope -4p 2 2
L
2 Combining equations and gives Co= 2p 2 iss Co=- FVslope where V AL is the volume of the drop of sample pipetted onto the tape. Since the parameters "slope" and "iss" are measured in the test and p and F are universal constants, -9to measure the concentration of the analyte derived from the test (Co) it is only required to know the volume of the sample pipetted. Since this can be done very accurately it is possible to have a very accurate measure of Co without the need for any other calibration of the system. Significantly, neither the spacing between the electrodes nor the electrode 00 5 area wetted need be known.
The exact shape adopted by the droplet in contact with the two electrodes is not important.
If desired the chemistry of successive electrode locations could be different one from another so that a multiplicity of different tests could be performed on successive pipetted volumes of sample placed at successive electrode locations. In a second embodiment as shown in Figure 3 which corresponds to the portion of Figure 1 upstream from sample station S, the first electrode is provided with an overlying layer 7 for example of a thin PET film from which apertures have been punched to define wells 8 into which chemical reagents 4 can be placed, and which served to define the locations at which reagents have been placed and/or to protect the reagents prior to use. In this case electrode 1 is conveniently supplied to the apparatus from a roll having predetermined quantities of chemical reagents in the wells in dried form and protected from contamination prior to use by being sandwiched between layers of the roll. The chemical reagents are only used once and therefore can be more easily protected against deterioration than is possible with prior art. In the above described embodiment the sample droplet 5 is not "contained" by a cell although it may be deposited and located within a well 8. When a well-defining layer 7 is employed it may be adhered to the electrode surface or electrode carrier or it may merely be Na non-adhered spacer layer.
It is not necessary for the upper electrode layer 11 to come into contact with the top 00 surface of the well-defining layer 7. The volume of sample pipetted is such that the height of drop 5 is equal to or preferably greater than the thickness of the well-defining layer 7. If a layer 7 is used to define a well 8, it is undesirable for the sample volume to run to the sides of the well. It is sufficient that the sample is a known volume and wets both electrodes preferably forming a substantially cylindrical shape therebetween.
It will also be understood that the well-defining layer 7 can be replaced with a porous layer for example a porous paper, non-woven mesh, or felt, or a porous membrane, which acts to immobilise the sample spatially with respect to the electrode layers and to hold the reagents in place and in this case the second electrode will contact the surface of the porous layer immobilising the volume.
It will be understood that use of a porous or well-defining layer 7 is optional and that in other embodiments of the invention a layer 7 is unnecessary it being sufficient for a drop of sample to be pipetted onto a metal layer 2 and for an upper metal layer 12 to be brought into contact with a sample drop of predetermined volume, upper metal layer 12 being desirably but not essentially at a predetermined spacing from the lower metal layer 1.
It will also be understood that the metal layer tapes or bands need not be travelling in the same direction. For example, one metallised electrode layer may be proceeding transversely of the other, each tape being advanced after each measurement to expose a fresh lower and fresh upper electrode surface and fresh reagent at the sample filling station.
-11- (In each case the resulting current is measured as a function of time while the electrodes are in contact with a sample drop of predetermined volume.
N Continuous band electrodes are preferred. These may either be disposed of after use N or may be passed through a washing station and then reused, if desired after reprinting with 00 5 reagents.
In preferred embodiments of the invention predetermined quantities of reagent are placed on one or both of the electrodes by metering devices for example an ink jet printhead upstream of sample station 3 and may, but need not, be dried prior to contact with the sample. A reagent application system may be a part of the apparatus, or the apparatus may be adapted to receive electrodes in roll or other form pretreated with the desired reagents at another location or plant.
It will be understood that one or both electrodes need not be a continuous band but may, for example, be in the form of a retractable probe. The second electrode could be a disposable probe lowered into contact with a droplet on a first electrode and then withdrawn after current measurements are completed. Likewise the first electrode need not be in the form of a tape. The first electrode could for example be mounted to a carousel or be in the form of a rotating disc. Although it is preferred to use disposable electrode surfaces, the method may be applied with reusable electrodes washed in between successive uses. By way of example, there is shown schematically in Figure 4 an automatic analysing apparatus comprising a first electrode 1 in the form of a first disc driven intermittently in rotation about a first horizontal axis. A second electrode 11 is driven intermittently and synchronously with the first disc in rotation about a horizontal axis parallel to the first axis. Electrodes 1 and 11 are spaced apart at their edge at the closest point of approach. Sample drops 5 of precisely predetermined volume are 12- (1deposited on the first electrode at intervals by a pipetting device 6 in synchronisation with the disc rotation. Reagents 4 are printed on the second electrode at corresponding intervals N by means of a printing roll 16 and are dried in situ, for example by an air blower (not C shown in the drawing).
00 In use, as electrode 1 rotates, a drop 5 travels to a position where it comes into Scontact with the second electrode and with the reagents printed thereupon. While both Sdiscs are stationary with the droplet in contact with each electrode, a potential is applied between the electrodes and the current measured as previously discussed. During this time the reagent(s) dissolve in the sample and after the necessary measurements have been made, both electrodes are indexed to a new angle of rotation. The surfaces used for the analysis are washed clean by sprays 14, into drained sumps 15 and ready for reuse.
Apparatus according to the invention requires very much smaller samples than are required with the YSI device and because the chemical reagents can be better protected until used and more accurately metered, the apparatus provides greater accuracy and speed at reduced cost.
In another embodiment of the invention the current can be followed with time after a potential has been applied between the electrodes until a predetermined time or state has been reached. The sign of the applied potential would then be reversed and analysis performed similar to that given above except with equations and being replaced with Dt i=iss(l+4exp(-4 2 (7) I i 4p L 2 (8) 13 (This protocol has the advantage of being able to allow for slow processes occurring in the test. This can be done by: N a) waiting for the current to change by less than a predetermined amount per second before reversing the potential, such that any slow processes which effect the measurement are substantially complete, N or b) using the change in the current with time before the potential is reversed to compensate for the slow processes occurring (as has been described in our earlier patent applications in relation to cells having a predefined electrode separation and area).
Although the invention has been described with reference to palladium electrodes, the electrodes can be of other suitable metals such as described for example in our earlier applications referred to herein. One electrode may be different from the other. The electrodes may be supported by PET as exemplified above or by other suitable insulating materials or may be self-supporting. If supported on an insulating film, it is preferred, but not essential, that the metals be deposited on the film by sputter coating. Electrical contact for the application of a potential and/or for the measurement of current may be by any suitable means including clamping engagement with one end of the electrode if in the form of a tape, or by means of suitable rolling contacts, or springloaded contacts, or the like.
The application of the electrical potential; the measurement of current; the calculation of the concentration of analyte; the synchronous control of the movement of one electrode with respect to the other and with the deposition of sample droplets and, if required, with the deposition of reagents may be controlled by a microprocessor or the like and the results may be printed, displayed, and/or otherwise recorded by means which are well-known to those skilled in the control arts.
o -14c As will be appreciated by those skilled in the art from the teaching hereof the features
D
Sof one embodiment may be combined with those of another and the invention may be c embodied in other forms without departing from the concepts herein disclosed.
(N)
00 2005200832 24 Feb 2005 TABLE 1I_ ANALYTE ENZYMES REDOX MEDIATOR ADDITIONAL MEDIATOR ____(OXIDISED FORM) Glucose GDHpqq Ferricyanide Glucose (NAD dependent) Glucose dehydrogenase and diaphorase Ferricyanide Cholesterol Cholesterol esterase and cholesterol Ferricyanide 2,6-dimethyl- 1,4-benzoqumnone oxidase dichloro- 1,4-benzoqumnone or phenazine ethosulfate HDL cholesterol Cholesterol esterase and cholesterol Ferricyanide 2,6-dimethyl-1 ,4-benzoqumnone oxidase dichloro- 1 ,4-benzoquinone or phenazine ethosulfate Triglycerides Lipoprotein lipase, glycerol kinase, and Ferricyanide or phenazmne ethosulphate Phenazine, methosulfate glycerol-3 -phosphate oxidase Lactate Lactate oxidase Ferricyanide 2,6-dichloro- 1 ,4-benzoqumnone Lactate Lactate dehydrogenase and diaphorase Ferricyanide, phenazine ethosulfate, or phenazine methosulfate Lactate dehydrogenase Diaphorase Ferricyamide, phenazine ethosulfate, or phenazine methosulfate Pyruvate Pyruvate oxidase Ferricyamide Alcohol Alcohol oxidase Phenylenediamine Bilirubin Bilirubin oxidase 1 -methoxy-phenazmne methosulfate Uric acid Uricase Ferricyanide
Claims (14)
1. A method for estimating the concentration of a reduced or oxidised form of a redox species in a liquid comprising the steps of: contacting an area of a first electrode with a sample of predetermined volume of tc, 00 5the liquid, N bringing a second electrode into a closely spaced relationship with the first Selectrode, thereby contacting the sample with an area of the second electrode spaced apart from the first electrode, wherein step is conducted after step and wherein at least one of the electrodes includes a reagent positioned thereon, applying a potential between the electrodes while the electrodes are sufficiently closely spaced such that reaction products formed at each electrode diffuse to the other electrode while the potential is applied, reversing the potential between the electrodes, measuring or estimating a value indicative of the change in current as a function of time and a value indicative of the steady state current, and determining from said value, said current as a function of time, and said steady state current the concentration of reduced or oxidised form of the species in the liquid sample.
2. A method according to claim 1, wherein the step of reversing the potential occurs after waiting for the current to change by less than a predetermined amount per time.
3. The method according to claim 1 or claim 2, further comprising the step of the change in current as a function of time before the potential is reversed to compensate for a slow chemical reaction step. -17- O
4. The method according to any one of the preceding claims, wherein the sample contacts the reagent during step The method according to any one of the preceding claims, wherein the sample contacts the reagent during step
6. The method according to any one of the preceding claims, wherein the sample is deposited on the reagent.
7. The method according to any one of the preceding claims, wherein at least one electrode is covered with a layer which serves to define wells on the electrode surface.
8. The method according to any one of the preceding claims, wherein at least one of the electrodes is in the form of a continuous strip.
9. The method according to any one of the preceding claims, wherein a pipette deposits the sample on the first electrode. The method according to any one of the preceding claims, wherein the first electrode further comprises a porous medium wherein the predetermined volume is immobilized.
11. The method according to any one of the preceding claims, further comprising the step of depositing one or more reagents on one of the electrodes prior to placing the sample on the electrode.
12. The method according to any one of the preceding claims, wherein at least one of the first and second electrodes includes at least one well.
13. The method according to any one of the preceding claims, wherein at least one of the first electrode and the second electrode is in the form of a disposable probe.
14. The method according to any one of the preceding claims, wherein at least one of the first electrode and the second electrode is in the form of a retractable probe. -18- The method according to any one of the preceding claims, wherein the first electrode comprises a first metallized electrode layer, wherein the second electrode Scomprises a second metallized electrode layer, and wherein the first metallized electrode layer travels transversely of the second electrode layer. (Ni 00 16. The method according to any one of claims 1 to 14, wherein the first electrode comprises a first metallized electrode layer, wherein the second electrode comprises a (ti Ssecond metallized electrode layer, and wherein the first metallized electrode layer travels in a same direction as the second electrode layer.
17. The method according to any one of the preceding claims wherein the sample of predetermined volume is a droplet deposited on one of said electrodes.
18. The method according to claim 17, wherein the droplet is held between the two electrodes by surface tension.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2005200832A AU2005200832B2 (en) | 1997-08-13 | 2005-02-24 | Method and apparatus for automatic analysis |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPO8558 | 1997-08-13 | ||
| AU44461/02A AU781184B2 (en) | 1997-08-13 | 2002-05-30 | Method and apparatus for automatic analysis |
| AU2005200832A AU2005200832B2 (en) | 1997-08-13 | 2005-02-24 | Method and apparatus for automatic analysis |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU44461/02A Division AU781184B2 (en) | 1997-08-13 | 2002-05-30 | Method and apparatus for automatic analysis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2005200832A1 AU2005200832A1 (en) | 2005-03-24 |
| AU2005200832B2 true AU2005200832B2 (en) | 2007-05-03 |
Family
ID=3731656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2005200832A Ceased AU2005200832B2 (en) | 1997-08-13 | 2005-02-24 | Method and apparatus for automatic analysis |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2005200832B2 (en) |
-
2005
- 2005-02-24 AU AU2005200832A patent/AU2005200832B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005200832A1 (en) | 2005-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6325917B1 (en) | Method and apparatus for automatic analysis | |
| US6863800B2 (en) | Electrochemical biosensor strip for analysis of liquid samples | |
| RU2305279C2 (en) | Device and method for determining concentration of reduced form or oxidized form of reduction-oxidation substance in liquid sample | |
| CA2328751C (en) | Microsphere containing sensor | |
| EP1252514B1 (en) | Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations | |
| JP3398598B2 (en) | Substrate quantification method and analytical element and measuring device used for the method | |
| US6174420B1 (en) | Electrochemical cell | |
| US7431814B2 (en) | Electrochemical cell | |
| KR101224499B1 (en) | Electrochemical assay device and related methods | |
| IL153209A (en) | Passive sample detection to initiate timing of an assay | |
| AU758963B2 (en) | Method and apparatus for automatic analysis | |
| AU2005200832B2 (en) | Method and apparatus for automatic analysis | |
| AU781184B2 (en) | Method and apparatus for automatic analysis | |
| AU7996798A (en) | Automatic analysing apparatus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |